UPDATE: Credit Suisse Starts Affimed Therapeutics (AFMD) at Outperform
Tweet Send to a Friend
(Updated - March 30, 2021 4:30 PM EDT)
Credit Suisse analyst Brad Canino initiates coverage on Affimed Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Credit Suisse analyst Brad Canino initiates coverage on Affimed Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
